hemolytic uremic syndrome


Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.

hemolytic uremic syndrome

[hē·mə¦lid·ik yə¦rēm·ik ′sin‚drōm]
(medicine)
An illness characterized by the abrupt onset of decreased urine production, loss of kidney function, and anemia. It may be accompanied by edema, hypertension, blood-clotting disorders, and seizures. It is often caused by infection with Escherichia coli O157:H7 but has also been associated with Salmonella and Shigella.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
Atkinson, "Complement regulatory genes and hemolytic uremic syndromes," Annual Review of Medicine, vol.
Ocular involvement in hemolytic uremic syndrome due to factor H deficiency are there therapeutic consequences.
Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome. Pediatr Nephrol 2011;26:1325-9.
* The report provides a snapshot of the global therapeutic landscape of Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome)
Hemolytic uremic syndrome has different etiological classifications in the literature (2, 5-7).
"Update on hemolytic uremic syndrome: diagnostic and therapeutic recommendations." World journal of nephrology 2.3 (2013): 56.
Abbreviations: ADAHTS13, a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13; aHUS, atypical hemolytic uremic syndrome; A-TTP, acquired thrombotic thrombocytopenic purpura; CTTP, congenital thrombotic thrombocytopenic purpura; HUS, hemolytic uremic syndrome; SPHUS, Streptococcus pneumoniae-associated hemolytic uremic syndrome; STEC-HUS, Shiga toxin-producing, Escherichia coli-associated hemolytic uremic syndrome; TPE, therapeutic plasma exchange.
Functional characterization of two novel non synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients.
Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome. Pediatric Nephrology, 26(4), 621-624.
Hemolytic uremic syndrome; pathogenesis, treatment, and outcome.
We also reviewed case records in the literature via search of PubMed using the terms of atypical hemolytic uremic syndrome and eculizumab and included cases with platelet counts within the first 7 days for assessment.
Razzaq, "Hemolytic uremic syndrome: an emerging health risk," The American Family Physician, vol.